1.
Vestn Ross Akad Med Nauk
; (7): 3-7, 2010.
Artigo
em Russo
| MEDLINE
| ID: mdl-20799405
RESUMO
With the growth of rheumatic morbidity the spectrum of medicines for its management needs to be extended. Selected aspects of etiology and clinical course of rheumatic diseases are discussed with reference to prospects of their application for etiopathogenetic therapy.
Assuntos
Citocinas/fisiologia , Doenças Reumáticas/imunologia , Imunidade Adaptativa , Autoimunidade , Infecções Bacterianas/complicações , Humanos , Imunidade Inata , Interferons/fisiologia , Interferons/uso terapêutico , Doenças Reumáticas/tratamento farmacológico , Doenças Reumáticas/etiologia , Viroses/complicações
2.
Zh Mikrobiol Epidemiol Immunobiol
; (1): 79-80, 2009.
Artigo
em Russo
| MEDLINE
| ID: mdl-19338241
RESUMO
Testing of immunocompromised patients for markers of beta-herpesviruses--human herpesvirus type 6 (HHV-6) and cytomegalovirus (CMV), as well as gamma-herpesvirus--Epstein-Barr virus (EBV), revealed that all mentioned infections are frequently detected, mainlyas mixed infections. Chronic HHV-6 infection was diagnosed in more than half of the patients, whereas markers of acute phase of CMV and EBV infections were detected in 25% and 15% of patients respectively.
